ATOM BIOSCIENCE & PHARMACEUTICAL

atom-bioscience-pharmaceutical-logo

Atom Bioscience is a clinical-stage biotechnology company developing new treatments for inflammatory and metabolic diseases such as chronic gout and non-alcoholic steatohepatitis.

#SimilarOrganizations #People #Financial #Website #More

ATOM BIOSCIENCE & PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Health Care

Founded:
2012-01-01

Address:
Suzhou, Jiangsu, China

Country:
China

Website Url:
http://www.atombp.com

Total Employee:
11+

Status:
Active

Email Addresses:
hui.yang@atpmbp.com

Total Funding:
160.15 M USD

Technology used in webpage:
Chinese Server Location


Similar Organizations

allogene-therapeutics-logo

Allogene Therapeutics

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

graphene-composites-logo

Graphene Composites

Graphene Composites is a nano-technology startup that combines graphene with aerogel .

immunos-therapeutics-logo

ImmunOs Therapeutics

ImmunOs Therapeutics is a clinical-stage biotechnology company.

kbp-biosciences-logo

KBP Biosciences

A multinational clinical stage biotechnology company.

lion-tcr-logo

Lion TCR

Lion TCR is a clinical-stage biotechnology company.

lyten-logo

Lyten

Lyten is an advanced materials company that developed Lyten 3D Graphene™

nuevocor-logo

Nuevocor

Nuevocor operates as a preclinical-stage biotech company.

olix-pharmaceuticals-logo

OliX Pharmaceuticals

OliX is a clinical stage biotechnology company.

panacea-biotec-logo

Panacea Biotec

Panacea Biotec is an Innovation driven Biotechnology company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.

Current Employees Featured

marc-gurwith_image

Marc Gurwith
Marc Gurwith Chief Medical Officer @ Atom Bioscience & Pharmaceutical
Chief Medical Officer

william-dongfang-shi_image

William (Dongfang) Shi
William (Dongfang) Shi CEO, President, Chairman, & Founder @ Atom Bioscience & Pharmaceutical
CEO, President, Chairman, & Founder

Founder


william-dongfang-shi_image

William (Dongfang) Shi

Investors List

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series D - Atom Bioscience & Pharmaceutical

unifortune_image

Unifortune

Unifortune investment in Series D - Atom Bioscience & Pharmaceutical

nnfe-fund-management_image

NNFE Fund Management

NNFE Fund Management investment in Series D - Atom Bioscience & Pharmaceutical

huajin-securities_image

HuaJin Securities

HuaJin Securities investment in Series D - Atom Bioscience & Pharmaceutical

fortune-capital_image

Fortune Capital

Fortune Capital investment in Series D - Atom Bioscience & Pharmaceutical

shenzhen-gtja-investment-group_image

ShenZhen GTJA Investment Group

ShenZhen GTJA Investment Group investment in Series C - Atom Bioscience & Pharmaceutical

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Series C - Atom Bioscience & Pharmaceutical

kaitai-capital_image

Kaitai Capital

Kaitai Capital investment in Series C - Atom Bioscience & Pharmaceutical

kingray-capital_image

Kingray Capital

Kingray Capital investment in Series C - Atom Bioscience & Pharmaceutical

livzon-pharmaceutical-group_image

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group investment in Series C - Atom Bioscience & Pharmaceutical

Official Site Inspections

http://www.atombp.com Semrush global rank: 12.98 M Semrush visits lastest month: 78

  • Host name: 43.143.100.25
  • IP address: 43.143.100.25
  • Location: Japan
  • Latitude: 35.69
  • Longitude: 139.69
  • Timezone: Asia/Tokyo

Loading ...

More informations about "Atom Bioscience & Pharmaceutical"

Atom Bioscience & Pharmaceutical - Crunchbase

Headquarters Regions Asia-Pacific (APAC); Founded Date 2012; Founders William (Dongfang) Shi; Operating Status Active; Last Funding Type Series D; Also Known As Atom Bioscience, …See details»

Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.

Nov 1, 2024 JIANGSU, China--(BUSINESS WIRE)-- Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new …See details»

Atom Therapeutics and China Medical System Holdings Enter …

Dec 3, 2024 Atom Therapeutics and CMS will execute a Contract Sales Organization (CSO) business model. Under the agreement, Atom Therapeutics will receive a substantial sum from …See details»

About Atom - Atom Bioscience

Atom Therapeutics is a research-based pharmaceutical company engaged in new drug discovery and development on treatments for inflammatory and metabolic diseases. Among our drugs …See details»

News & Events - Atom Bioscience

Jan 2, 2024 News from Atom Therapeutics 21 May, 2024 Atom Bioscience Marks Gout Awareness Day with Video Detailing Risks of Hyperuricemia, the Cause of Gout PRESS …See details»

Jiangsu Atom Bioscience and Pharmaceutical Co. Ltd.

Feb 6, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. Jiangsu Atom …See details»

Atom Bioscience Names Hu Xianjun Clinical VP in China

Apr 21, 2024 PRESS RELEASE Atom Bioscience Names Hu Xianjun Clinical VP in China JIANGSU, China (April 18, 2024) – Atom Bioscience (Jiangsu Atom Bioscience and …See details»

Atom Bioscience and Pharmaceutical - Overview, News ... - ZoomInfo

View Atom Bioscience and Pharmaceutical (www.atombp.com) location in Jiangsu, China , revenue, industry and description. Find related and similar companies as well as employees …See details»

Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd.

了解Jiangsu Atom Bioscience & Pharmaceutical Co., Ltd. (江苏新元素医药科技有限公司)公司的药物管线,治疗领域,技术平台,以及它的10项临床试验, 48篇新闻,疾病领域:内分泌与代谢疾 …See details»

Atom Bioscience and Pharmaceutical - Datanyze

John@atombp.com: 7: last: Smith@atombp.com: Your Questions, Our Answers Get Free Access to Atom Bioscience and Pharmaceutical Contacts Info. What is Atom Bioscience and …See details»

Atom Bioscience获得8300万美元D轮融资,用于支持慢性痛风新疗 …

Oct 16, 2023 JIANGSU, China--(BUSINESS WIRE)--Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing best-in …See details»

Atom Therapeutics and China Medical System Holdings Enter

Dec 3, 2024 Atom Therapeutics and CMS will execute a Contract Sales Organization (CSO) business model. Under the agreement, Atom Therapeutics will receive a substantial sum from …See details»

Atom Bioscience Raises $45 Million in Series C Round of

Jan 5, 2022 JIANGSU, China--(BUSINESS WIRE)-- Atom Bioscience (Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.), a clinical stage biotechnology company developing new …See details»

Atom Therapeutics and China Medical System Holdings Enter …

Dec 3, 2024 Atom Therapeutics Co. Ltd (Atom Therapeutics), a clinical stage biotechnology company developing best-in-class treatments for inflammatory and metabolic diseases, …See details»

Atom Bioscience Receives FDA IND Clearance for Clinical Trial of …

Jan 2, 2024 The company’s lead product, ABP-671, is in Phase 2b/3 clinical development for treatment of chronic gout . Another small molecule ABP-745 has shown significant efficacy …See details»

ABP-745 - Drug Targets, Indications, Patents - Synapse - Patsnap

Nov 21, 2024 ABP-745 is an oral small molecule drug that also has potential applications for other anti-inflammatory diseases JIANGSU, China--(BUSINESS WIRE)-- Atom Bioscience …See details»

Atom Bioscience Raises $47 Million in Series C Round of Financing …

Jan 5, 2022 Atom Bioscience Raises $47 Million in Series C Round of Financing to Advance Development of Small Molecule Drugs for Inflammatory and Metabolic Diseases Funding will …See details»

Atom Therapeutics Receives FDA IND Clearance for ... - Atom …

Jan 19, 2024 The company’s lead product, ABP-671, is in Phase 2b/3 clinical development for treatment of chronic gout . Another small molecule ABP-745 has shown significant efficacy …See details»

Lingdolinurad - Drug Targets, Indications, Patents - Synapse

Jan 4, 2025 Atom Therapeutics and CMS will execute a Contract Sales Organization (CSO) business model. Under the agreement, Atom Therapeutics will receive a substantial sum from …See details»

Atom Bioscience Changes Name to Atom Therapeutics To Better …

Nov 12, 2024 PRESS RELEASE Atom Bioscience Changes Name to Atom Therapeutics To Better Reflect Focus on Development of Best-in-Class Novel Oral Drugs for Inflammatory and …See details»

linkstock.net © 2022. All rights reserved